# TCIM

## Overview
The TCIM gene encodes a protein known as the transcriptional and immune response regulator, which plays a pivotal role in modulating transcriptional activities and immune responses. This protein is categorized as a regulatory protein due to its involvement in various cellular processes, including lipid metabolism and immune cell function. TCIM is implicated in the regulation of immune responses, particularly in the context of neural repair and viral infections, such as SARS-CoV-2, where it interacts with host proteins to influence viral replication and immune modulation (Karunakaran2020Interactome; Shaw2024Elevated). Additionally, TCIM's expression levels have been linked to clinical outcomes in several cancers, including medulloblastoma and thyroid cancer, highlighting its significance as a potential biomarker and therapeutic target (Han2024An; Guo2023Identification).

## Function


## Clinical Significance
The TCIM gene, also known as transcriptional and immune response regulator, has been implicated in various diseases due to alterations in its expression levels and interactions. In pediatric medulloblastoma (MB), high expression of TCIM is associated with worse overall survival, making it a significant risk factor for poor outcomes in these patients (Han2024An). Similarly, TCIM is linked to low-grade gliomas, where its high expression is also considered a risk factor (Han2024An).

In thyroid cancer (THCA), TCIM is identified as a protective gene within a senescence-related signature, suggesting its role in influencing prognosis and response to immunotherapy (Guo2023Identification). The study indicates that TCIM's expression is associated with better outcomes in THCA, contrasting its role in MB (Guo2023Identification).

TCIM also interacts with the Notch signaling pathway, where its high expression in T cells inhibits the nuclear translocation of the activated Notch2 intracellular domain. This interaction suppresses downstream effector molecules, reducing the cytotoxicity of CD8+ T cells and modulating the anti-tumor immune response (Li2023The). These findings highlight TCIM's complex role in cancer progression and immune regulation.

## Interactions
The TCIM gene, known for its role in transcriptional and immune response regulation, participates in various protein interactions that are crucial for its function. TCIM has been shown to interact with proteins involved in lipid trafficking, catabolism, and recycling, suggesting its involvement in lipid metabolism and immune cell reprogramming during spinal cord repair (Shaw2024Elevated). The TCIM interactome includes proteins that may directly interact with lipids or lipid membranes, facilitated by a putative intrinsically disordered region in TCIM (Shaw2024Elevated).

In the context of SARS-CoV-2 infection, TCIM has been identified as interacting with GOLGA7, a host protein, highlighting its potential role in the host-virus interactome. This interaction is part of a broader network of protein-protein interactions modulated by the virus, which may influence viral replication and immune response modulation (Karunakaran2020Interactome).

These interactions underscore TCIM's involvement in critical biological processes, including immune cell function and lipid metabolism, which are essential for both neural repair and the host response to viral infections. The study of TCIM's interactions provides insights into its multifaceted role in cellular processes and potential therapeutic targets.


## References


1. (Karunakaran2020Interactome) Interactome of SARS-CoV-2 / nCoV19 modulated host proteins with computationally predicted PPIs. This article has 12 citations.

[2. (Li2023The) Xinxin Li, Xianchun Yan, Yufeng Wang, Balveen Kaur, Hua Han, and Jianhua Yu. The notch signaling pathway: a potential target for cancer immunotherapy. Journal of Hematology &amp; Oncology, May 2023. URL: http://dx.doi.org/10.1186/s13045-023-01439-z, doi:10.1186/s13045-023-01439-z. This article has 36 citations.](https://doi.org/10.1186/s13045-023-01439-z)

[3. (Guo2023Identification) Yangyang Guo, Kenan Cen, Qiaoqiao Chen, Ying Dai, Yifeng Mai, and Kai Hong. Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy. Frontiers in Immunology, January 2023. URL: http://dx.doi.org/10.3389/fimmu.2023.1128390, doi:10.3389/fimmu.2023.1128390. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2023.1128390)

4. (Shaw2024Elevated) Elevated phagocytic capacity directs innate spinal cord repair. This article has 0 citations.

5. (Han2024An) An Immune Microenvironment-Associated Gene Signature Predicts Outcomes and Therapeutic Response in Pediatric Medulloblastoma. This article has 0 citations.